BILLS-117hr1730ih.pdf

2021 2 years 16 days 1730 IH MARCH 10, 2021 1 year annual 1ST SESSION H. R. 1730 180 days later than 90 days 4 years 21 years May 07, 2021 Jkt 019200

the ‘‘Speeding Therapy

PO 00000 Frm 00011 Fmt PO 00000 Frm 00010 PO 00000 Frm 00006 PO 00000 Frm PO 00000 Frm 00005 PO 00000 Frm 00009

1730 IH Treat- the United States of America

Cosmetic Insti-

SEC the Advisory Committee Rare Diseases and Conditions the Intercenter Institute Advisory Committee the Federal Food, Drug Congress Intercenter Institute Medicare & Medicaid Services Condition Drug Advisory Committee Disease Entities Program the Committee on Energy and Commerce THE HOUSE OF REPRESENTATIVES the Federal Food U.S.C. MEDICAID Health the Center for Drug the Food and Drug Administra- the Advancing Translational Sciences United the Center for Medicare Conditions Intercenter Institute on Rare Diseases and Conditions State Medicaid ernment the Food and Drug Administration the Department of Health and Human the National Center 12 Entities Program House of Representa- the Food and Drug Adminis- Health Insurance Institute on Rare Diseases and Conditions Evaluation and Research National Institutes of Health RESPONSIBILITIES.—In Centers Human Services COMMITTEE.—The Advisory the ‘Advisory Committee’ Senate Drug

the Accelerating Lifesavings BUTTERFIELD BILIRAKIS trator

rare diseases rare diseases conditions rare disease disease condition therapies diseases food drug federal food drug cosmetic cosmetic act cosmetic conditions drug regulatory